295 related articles for article (PubMed ID: 38137363)
1. Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus.
Miñano S; González-Correa C; Moleón J; Duarte J
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137363
[TBL] [Abstract][Full Text] [Related]
2. [Immunometabolism and systemic lupus erythematosus].
Xiao YB; Guo MY; Zuo XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE.
Wolf VL; Phillips TL; Taylor EB; Sasser JM; Ryan MJ
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H234-H242. PubMed ID: 31125285
[TBL] [Abstract][Full Text] [Related]
4. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.
Tumurkhuu G; Montano E; Jefferies C
Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604
[TBL] [Abstract][Full Text] [Related]
5. Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update.
Romo-Tena J; Kaplan MJ
Curr Opin Rheumatol; 2020 Nov; 32(6):562-571. PubMed ID: 32826478
[TBL] [Abstract][Full Text] [Related]
6. Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions.
Saadh MJ; Kazemi K; Khorramdelazad H; Mousavi MJ; Noroozi N; Masoumi M; Karami J
Int Immunopharmacol; 2023 Jun; 119():110246. PubMed ID: 37148769
[TBL] [Abstract][Full Text] [Related]
7. Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study.
Moleón J; González-Correa C; Robles-Vera I; Miñano S; de la Visitación N; Barranco AM; Martín-Morales N; O'Valle F; Mayo-Martínez L; García A; Toral M; Jiménez R; Romero M; Duarte J
Gut Microbes; 2023 Dec; 15(2):2247053. PubMed ID: 37615336
[TBL] [Abstract][Full Text] [Related]
8. A cellular overview of immunometabolism in systemic lupus erythematosus.
Psarras A; Clarke A
Oxf Open Immunol; 2023; 4(1):iqad005. PubMed ID: 37554724
[TBL] [Abstract][Full Text] [Related]
9. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
Tzeng HT; Chyuan IT
J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
[TBL] [Abstract][Full Text] [Related]
10. Estrogen in cardiovascular disease during systemic lupus erythematosus.
Gilbert EL; Ryan MJ
Clin Ther; 2014 Dec; 36(12):1901-1912. PubMed ID: 25194860
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications.
Yennemadi AS; Keane J; Leisching G
Lupus; 2023 Apr; 32(5):603-611. PubMed ID: 36914582
[TBL] [Abstract][Full Text] [Related]
13. Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking "Inflammaging" in Patients with Systemic Lupus Erythematosus.
Tsai CY; Shen CY; Liao HT; Li KJ; Lee HT; Lu CS; Wu CH; Kuo YM; Hsieh SC; Yu CL
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395799
[TBL] [Abstract][Full Text] [Related]
14. Immunometabolism in the pathogenesis of systemic lupus erythematosus.
Zhang CX; Wang HY; Yin L; Mao YY; Zhou W
J Transl Autoimmun; 2020; 3():100046. PubMed ID: 32743527
[TBL] [Abstract][Full Text] [Related]
15. Immmunometabolism of systemic lupus erythematosus.
Furment MM; Perl A
Clin Immunol; 2024 Apr; 261():109939. PubMed ID: 38382658
[TBL] [Abstract][Full Text] [Related]
16. Immunometabolism in systemic lupus erythematosus.
Morel L
Nat Rev Rheumatol; 2017 May; 13(5):280-290. PubMed ID: 28360423
[TBL] [Abstract][Full Text] [Related]
17. Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.
Taylor EB; Sasser JM; Maeda KJ; Ryan MJ
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1274-F1284. PubMed ID: 30892934
[TBL] [Abstract][Full Text] [Related]
18.
Toral M; Robles-Vera I; Romero M; de la Visitación N; Sánchez M; O'Valle F; Rodriguez-Nogales A; Gálvez J; Duarte J; Jiménez R
FASEB J; 2019 Sep; 33(9):10005-10018. PubMed ID: 31173526
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of EZH2 Is Mediated by Higher Glycolysis and mTORC1 Activation in Lupus CD4
Zheng X; Tsou PS; Sawalha AH
Immunometabolism; 2020; 2(2):. PubMed ID: 32395334
[TBL] [Abstract][Full Text] [Related]
20. The Intersection of Cellular and Systemic Metabolism: Metabolic Syndrome in Systemic Lupus Erythematosus.
Terrell M; Morel L
Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35560001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
